The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection: Are the data found in this sample applicable to other settings?

Cusinato, Catiane Tiecher; Koetz, Ana Paula Messa; Barcellos, Nêmora Tregnago; Wolff, Fernando Herz

doi:10.1002/hep.26172

Cited by 6 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recently it became evident that HCC in HIV/HCV co‐infected patients develop HCC at a very early stage of life, such as in the 30s and 40s . The molecular mechanism of its development still remains unclear, but surveillance in those patients should be considered for HCC strictly.…”

Section: Upcoming Topics Regarding Lt Indications For Hiv/hcv Co‐infementioning

confidence: 99%

“…In this review, the outcome and the points of management of LT for HIV/HCV co‐infected patients were reviewed to save relatively young patients with HIV/HCV co‐infection bearing HCC , non‐cirrhotic portal hypertension (NCPH) , and decompensated liver cirrhosis . An updated critical review of the literature in 2013 was performed, and new information on problems and results for LT for HIV/HCV co‐infection were included.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus co‐infection: update in 2013

Eguchi

Takatsuki

Kuroki

2013

J Hepato Biliary Pancreat

View full text Add to dashboard Cite

Because of the progress of anti-retroviral therapy (ART) for human immunodeficiency virus (HIV), mortality due to opportunistic infection resulting in AIDS has been remarkably reduced. However, meanwhile, half of those patients have died of end-stage liver cirrhosis due to hepatitis C virus (HCV) with liver cirrhosis and early occurrence of hepatocellular carcinoma. Recently, in 2013, noncirrhotic portal hypertension due to ART drugs or still unknown mechanisms have become problematic with early progression of the disease in this patient population. Liver transplantation (LT) could be one treatment of choice in such cases, but the indications for LT perioperative management, including both HIV and HCV treatments and immunosuppression, are still challenging. In this review, we update the literature on HIV/HCV co-infection and LT as well as recent effort for modifying allocation system for those patients.

show abstract

Section: Upcoming Topics Regarding Lt Indications For Hiv/hcv Co‐infementioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus co‐infection: update in 2013

Eguchi

Takatsuki

Kuroki

2013

J Hepato Biliary Pancreat

View full text Add to dashboard Cite

show abstract

“…However, as the survival of HIV-infected people has improved due to the widespread use of antiretroviral therapy, the mortality due to HCV-related liver disease has increased in HIV/HCV co-infected patients 2,3 .…”

Section: Introductionmentioning

confidence: 99%

Analysis of the Hepatic Functional Reserve, Portal Hypertension, and Prognosis of Patients With Human Immunodeficiency Virus/Hepatitis C Virus Coinfection Through Contaminated Blood Products in Japan

Eguchi

Takatsuki

Soyama

et al. 2014

Transplantation Proceedings

View full text Add to dashboard Cite

Background: As the survival of HIV-infected individuals has improved due to the widespread use of antiretroviral therapy, the mortality rate due to HCV-related liver disease has increased in HIV/HCV co-infected patients. Aim: 1. To establish the appropriate therapeutic strategy for HIV/HCV co-infected patients by evaluating the liver function, including the hepatic functional reserve and portal hypertension. 2. To investigate the prognosis of HIV/HCV co-infected patients in Japan. Patients and

show abstract

Epidemiological and etiological variations in hepatocellular carcinoma

et al. 2019

View full text Add to dashboard Cite

The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection: Are the data found in this sample applicable to other settings?

Cited by 6 publications

References 6 publications

Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus co‐infection: update in 2013

Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus co‐infection: update in 2013

Analysis of the Hepatic Functional Reserve, Portal Hypertension, and Prognosis of Patients With Human Immunodeficiency Virus/Hepatitis C Virus Coinfection Through Contaminated Blood Products in Japan

Epidemiological and etiological variations in hepatocellular carcinoma

Contact Info

Product

Resources

About